Status:

COMPLETED

Validation of the Turkish Swallowing Disturbance Questionnaire

Lead Sponsor:

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Conditions:

Parkinson Disease

Dysphagia

Eligibility:

All Genders

18-80 years

Brief Summary

Purpose of the study is the validity and reliability of the Turkish version of the Swallowing Disturbance Questionnaire (SDQ-T), so that it would be used as an assessment tool for Turkish Parkinson Di...

Detailed Description

Parkinson's disease (PD) patients who suffered from dysphagia have reported significantly reduced quality of life. The swallow function is a multidirectional process that depends on complex neuro-musc...

Eligibility Criteria

Inclusion

  • Diagnosed with Parkinson's disease
  • Able to speak, read, understand and write in Turkish
  • Taking food orally
  • Malignancy
  • Having an active infection
  • Advanced demans or

Exclusion

  • Diagnosed with other neurodegenerative disorders.
  • Able not to speak, read, understand and write in Turkish
  • Advanced demeans or other cognitive limitations
  • Underwent any surgery last six months
  • Pregnancy
  • Underwent laryngectomy/neck dissection/tracheostomy/neck radiotherapy
  • Out of age 18-80 years old.

Key Trial Info

Start Date :

December 7 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 7 2021

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT04737811

Start Date

December 7 2020

End Date

March 7 2021

Last Update

August 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Prof Dr Cemil Tascioglu City Hospital

Istanbul, Turkey (Türkiye), 34384